Live Breaking News & Updates on President Fresenius Kabi

Stay updated with breaking news from President fresenius kabi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Formycon and Fresenius Kabi announce File Acceptance for FYB202, a biosimilar candidate to Stelara®

EQS-News: Formycon AG / Key word(s): Regulatory AdmissionFormycon and Fresenius Kabi announce File Acceptance for FYB202, a biosimilar candidate to Stelara® (ustekinumab), by the U.S. Food and Drug Administration 30.11.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press R. ....

United States , Stefan Glombitza , Fresenius Kabi , Drug Administration , Distribution Services , Corporate Communications , Regulatory Admission , File Acceptance , Biologics License Application , Michael Sch , President Fresenius Kabi , Investor Relations , Corporate News , Regulatory Announcements ,